A Phase III, Multicenter, Double Blind, Randomized Study of SII Yellow Fever Vaccine to Compare Safety and Immunogenicity With STAMARIL
Condition: Yellow Fever Interventions: Biological: STAMARIL; Biological: SII-YFV Sponsor: Serum Institute of India Pvt. Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 16, 2022 Category: Research Source Type: clinical trials
A Study of SII Yellow Fever Vaccine to Compare Safety and Immunogenicity With STAMARIL
Condition: Yellow Fever Interventions: Biological: STAMARIL; Biological: SII-YFV Sponsor: Serum Institute of India Pvt. Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 16, 2022 Category: Research Source Type: clinical trials